OTC: EKTAF - Elekta AB (publ)

Rentabilidade por seis meses: -15.52%
Rendimento de dividendos: +0.03%
Setor: Healthcare

Cronograma de promoção Elekta AB (publ)


Sobre a empresa Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.

mais detalhes
It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета sek
Див.доход ао 0.0299
Дивиденд ао 0.1167
Сайт https://elekta.com
Цена ао 5.66
Alteração de preço por dia: 0% (5.66)
Alteração de preço por semana: -5.67% (6)
Alteração de preço por mês: +4.04% (5.44)
Alteração de preço em 3 meses: -4.07% (5.9)
Mudança de preço em seis meses: -15.52% (6.7)
Mudança de preço por ano: -21.61% (7.22)
Mudança de preço em 3 anos: -55.85% (12.82)
Mudança de preço em 5 anos: -35.39% (8.76)
Mudança de preço em 10 anos: 0% (5.66)
Mudança de preço desde o início do ano: +0.177% (5.65)

Subestimação

Nome Significado Nota
P/S 1.74 8
P/BV 2.93 6
P/E 24.24 6
EV/EBITDA 10.97 7
Total: 6.13

Eficiência

Nome Significado Nota
ROA, % 4.23 1
ROE, % 12.7 4
Total: 3.83

Dividendos

Nome Significado Nota
Div yield, % 0.0291 0.08
DSI 0.8571 8.57
Total: 3.3

Obrigação

Nome Significado Nota
Debt/EBITDA 2.21 6
Total: 4.8

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 24.09 4
Rentabilidade Ebitda, % 2.18 1
Rentabilidade EPS, % 19.99 3
Total: 4.4



Supervisor Cargo Pagamento Ano de nascimento
Dr. Laurent Leksell Founder & Chairman 1.64M 1952 (73 ano)
Mr. Gustaf Salford President & CEO 14.62M 1977 (48 anos)
Mr. Tobias Hagglov Chief Financial Officer N/A 1978 (47 anos)
Mr. Jonas Bolander Executive VP of Group Functions, Secretary & General Counsel N/A 1966 (59 anos)
Mr. Mattias Thorsson VP and Head of Corporate Communications & Public Affairs N/A
Ms. Anna Conneryd Lundgren Executive VP & Chief People Officer N/A 1985 (40 anos)
Mr. John Lapré President of Brachy & Neuro Solutions N/A 1964 (61 ano)
Mr. Maurits Wolleswinkel President of Linac & Software Solutions N/A 1971 (54 ano)
Mr. Habib Nehme Chief Commercial Officer N/A 1964 (61 ano)
Mr. Peter Nyquist Head of Investor Relations N/A 1965 (60 anos)

Endereço: Sweden, Stockholm, Hagaplan 4 - abrir no Google Maps, abrir mapas Yandex
Site: https://elekta.com